Conversion surgery after gemcitabine and cisplatin plus durvalumab for advanced intrahepatic cholangiocarcinoma: A case report

doi:10.12998/wjcc.v12.i34.6721

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (151)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

HTML

124

Figures (1-3)

Sum=140

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=3

Dec 6, 2024 (publication date) through Oct 14, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Dec 6, 2024; 12(34): 6721-6727
Published online Dec 6, 2024. doi: 10.12998/wjcc.v12.i34.6721

Full Size Figure Download Figure

Figure 2 Changes in carcinoembryonic antigen and carbohydrate antigen 19-9 tumor marker levels and timeline of the gemcitabine and cisplatin plus durvalumab regimen. Numbers 1–8 indicate the treatment cycle. “D” indicates durvalumab maintenance therapy. CA 19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen.

Citation: Igata Y, Kudo M, Kojima M, Kami S, Aoki K, Satake T, Kobayashi T, Sugimoto M, Kobayashi S, Konishi M, Gotohda N. Conversion surgery after gemcitabine and cisplatin plus durvalumab for advanced intrahepatic cholangiocarcinoma: A case report. World J Clin Cases 2024; 12(34): 6721-6727
URL: https://www.wjgnet.com/2307-8960/full/v12/i34/6721.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i34.6721